Results for
""Liraglutide""[mesh_terms]

▾ Liraglutide for weight management.

Drug and therapeutics bulletin 2018;55(7):78-81

Liraglutide in Prader Willi-Syndrome: The Importance of Placebo-Controlled Studies.

Rita A Gómez Díaz, Carlos A Aguilar Salinas

The Journal of clinical endocrinology and metabolism 2023;108(7):e493-e494

Liraglutide for the Treatment of Obesity: Analyzing Published Reviews.

Josep A Tur, Rosario Pastor

Current pharmaceutical design 2020;25(15):1783-1790

Super response to liraglutide in people with obesity: A case report and literature review.

Javier Escalada, Elena Sánchez Campayo, Sonsoles Guadalix, Sonsoles Gutiérrez Medina

Endocrinologia, diabetes y nutricion 2024;71(10):447-453

Insufficient sleep predicts poor weight loss maintenance after 1 year.

Adrian F Bogh, Simon B K Jensen, Christian R Juhl, Charlotte Janus, Rasmus M Sandsdal, Julie R Lundgren, Mikkel H Noer, Nhu Q Vu, Matteo Fiorenza, Bente M Stallknecht, Jens J Holst, Sten Madsbad, Signe S Torekov

Sleep 2023;46(5):zsac295

Plain Language Summary

Free Full Text

Abstract

Incretin-Based Weight Loss Pharmacotherapy: Can Resistance Exercise Optimize Changes in Body Composition?

Juliene Gonçalves Costa, João Carlos Locatelli, Daniel J Green, Bu B Yeap, Louise H Naylor, P Gerry Fegan, Andrew Haynes

Diabetes care 2024;47(10):1718-1730

Oral semaglutide for type 2 diabetes: A systematic review and meta-analysis.

Thomas Karagiannis, Eleni Bekiari, Apostolos Tsapas, David R Matthews, Aris Liakos, Theodoros Michailidis, Ioannis Avgerinos

Diabetes, obesity & metabolism 2021;22(3):335-345

Liraglutide for Weight Management in Children and Adolescents With Prader-Willi Syndrome and Obesity.

Moris Angulo, Gwenaëlle Diene, Paula M Hale, Maïthé Tauber, Serap Turan, Chethana Ramesh, Anita Hokken-Koelega, Paul L Hofman, Cecilie H Jepsen

The Journal of clinical endocrinology and metabolism 2022;108(1):4-12

Obesity: a gender-view.

G Muscogiuri, A Colao, S Savastano, L Barrea, C Vetrani, L Verde

Journal of endocrinological investigation 2024;47(2):299-306

Plasma metabolites associated with functional and clinical outcomes in heart failure with reduced ejection fraction with and without type 2 diabetes.

Svati H Shah, G Michael Felker, Adrian F Hernandez, Stephanie N Giamberardino, Joseph B Lerman, Robert W McGarrah

Scientific reports 2022;12(1):9183

Type 2 diabetes in children and adolescents: distinct characteristics and evidence-based management.

Alexandra Soldatou, Foteini Karachaliou, Nicholas Tentolouris, Stavroula A Paschou, Kyriaki Karavanaki

Endocrine 2022;78(2):280-295

A systematic review of licensed weight-loss medications in treating antipsychotic-induced weight gain and obesity in schizophrenia and psychosis.

Kenn Lee, Robert Cleaver, Seri Abraham

General hospital psychiatry 2022;78():58-67

Treatment of persistent or recurrent type 2 diabetes after metabolic surgery.

Geltrude Mingrone

The lancet. Diabetes & endocrinology 2020;7(7):504-505

Effects of Treatment with Liraglutide Early after Surgical Intervention on Clinical Outcomes in Patients with Short Bowel Syndrome: A Pilot Observational "Real-Life" Study.

Simona Bo, Valentina Ponzo, Leila Cravero, Mirko Ippolito, Marta Ossola, Umberto Aimasso, Fabio Dario Merlo

Nutrients 2023;15(12):2740

A Single-dose, Two-Period Crossover Bioequivalence Study Comparing Two Liraglutide Formulations in Healthy Chinese Subjects.

Xu Su, Yan Liu, Fengshan Li, Feng Hu, Dan Du, Weiyi Guo, Qin Zou, Chunfeng Du, Zhuo Chen, Wenjing Hao, Qin Yu, Xiaoyan Wang, Linrui Cai, Shiyin Feng, Junjie Cai

Clinical pharmacology in drug development 2023;12(4):385-391